DURHAM, NC., June 02, 2026 (GLOBE NEWSWIRE) -- Galaxy Diagnostics , a leader in advanced vector-borne disease testing, has announced a strategic investment from Bay Area Lyme Ventures, the newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results